Skip to content
Search

Latest Stories

PCR tests close in NI but lateral flow test kits continue to be available in community pharmacies

Northern Ireland has announced the closure of free polymerase chain reaction (PCR) test for Covid-19 but lateral flow tests will continue to be free for patients displaying symptoms or people visiting high-risk settings and those providing close personal care.

Anyone with symptoms will no longer be required to take a PCR test, with all testing sites across Northern Ireland closing from Friday (April 22). Instead, people with symptoms have been advised to take lateral flow tests which are still available in over 500 community pharmacies across the country. Those who don’t have symptoms are no longer required to take a lateral flow test, unless they are visiting higher risk settings such as care homes, hospices or hospitals.


Deputy chief medical officer Dr Lourda Geoghegan said: “While prevalence of the virus remains high, the risk of serious illness has been significantly reduced – largely due to the success of our vaccination programme and the use of new Covid-19 treatments. As signalled in the department’s transition plan, these changes are proportionate and necessary at this stage of the pandemic.

“Transmission of Covid-19 in health and social care settings remains a risk and adds to the demands and pressures on our workforce. Anyone visiting friends or family in these settings should continue to take a lateral flow test before their visit.”

Isolation guidance for household contacts is also changing. Daily lateral flow testing is no longer advised. Household contacts are asked to be alert to symptoms and should only test if they develop symptoms. This applies to both vaccinated and unvaccinated household contacts. There is no change at this time to the guidance on isolation for positive cases.

Concluding, Dr Geoghegan said: “At this time it is important that we focus contact tracing services to help protect those at higher risk. Household contacts of a positive case are at greater risk of contracting the virus.

"Positive cases and their households will therefore continue to be provided with the necessary public health advice. It also remains vital that those at higher risk and who may be eligible for Covid-19 treatments, take a lateral flow test as soon as symptoms develop, even if symptoms are mild, as treatments should commence quickly following a positive test result.

“I urge everyone to find out if they are eligible to access lateral flow tests under the new arrangements by visiting NI Direct. We should continue to protect those at higher risk by testing if we have symptoms and isolating if we receive a positive test result.”

Test and Trace policy will be kept under review during the ongoing period of transition up until the end of June.

More For You

Homecare medicines services face many challenges beyond pharmacy's control

Homecare medicines services face many challenges beyond pharmacy's control

gettyimages

GPhC calls for industry-wide collaboration to strengthen homecare medicines services

The General Pharmaceutical Council (GPhC) has called for industry-wide collaboration to improve homecare medicines services to ensure patients always receive their medicines when needed.

The call follows a recent review by the regulator, which identified several challenges facing homecare services, many of which were beyond the immediate control of the pharmacies providing them.

Keep ReadingShow less
Lack of funding deters NI pharmacy contractors from expanding portfolio

W G Hamilton Pharmacy is the third pharmacy in Northern Ireland to be recently sold to first-time buyers.

Pharmacy ownership trends shift in Northern Ireland due to funding gap

An increasing number of pharmacies in Northern Ireland are being acquired by first-time buyers, as existing contractors and groups pull back from expanding their portfolios amid ongoing funding pressures, according to specialist business property adviser Christie & Co.

Among the most recent sales is W G Hamilton Pharmacy, a busy community pharmacy in Ballysillan, North Belfast.

Keep ReadingShow less
RPS backs Pharmacist Support "Gift in Wills" initiative

The ‘Gift in Wills’ initiative is delivered in partnership with Bequeathed.

Photo credit: gettyimages

Leave a legacy: RPS partners with Pharmacist Support to promote ‘Gift in Wills’

The Royal Pharmaceutical Society (RPS) has announced its support for the ‘Gift in Wills’ initiative run by Pharmacist Support, coinciding with the charity’s birthday celebrations today (Tuesday 15 April).

This collaboration allows RPS members to create a free will while also helping to safeguard the future of vital support services for the pharmacy profession.

Keep ReadingShow less
Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less